Study: CABG may boost survival in diabetes, CAD patients

06/21/2013 | MedWire News (U.K.)

Diabetes patients with multivessel coronary artery disease who underwent coronary artery bypass graft surgery showed lower rates of 10-year cardiac mortality and were also less likely to need additional intervention compared with those who received medical therapy, a study in the American Heart Journal revealed.

View Full Article in:

MedWire News (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD